Investor Ashish Kacholia has acquired nearly two percentage point stake in Vivimed Labs through open market. Ashish has purchased 1.37 million equity shares representing 1.7% of total equity of the pharmaceuticals company at an average price of Rs 90.50 per share on September 27.
RBA Finance & Investment also bought 2.2 million shares or 2.74% stake in the company at price of Rs 90.5 per share. Nylim Jacob Ballas India Fund III LLC had sold part of its holding via open market. It offloaded 4.88 million shares representing 6% of total equity of Vivimed Labs at an average price of Rs 93.65 per share.
Vivimed Labs is engaged in providing specialty chemicals and pharmaceuticals products. The company offers products for oral care, sun care, skin care, hair care, reversacol photochromic dyes, imaging chemicals and nisarg.
